Fasken Martineau was retained by a global pharmaceutical manufacturer to legally challenge various initiatives from provincial governments and administrative bodies to encourage the use of off-label drugs (unapproved drugs) over drugs that can be used on label (approved drugs). Fasken developed innovative solutions and represented the client in various related procedures.